Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion
Author's Department
Chemistry Department
Find in your Library
https://doi.org/10.1186/s12944-021-01581-y
Document Type
Research Article
Publication Title
Lipids in Health and Disease
Publication Date
12-1-2021
doi
10.1186/s12944-021-01581-y
Abstract
Cell surface biochemical changes, notably excessive increase in outer leaflet sphingomyelin (SM) content, are important in cancer initiation, growth, and immune evasion. Innumerable reports describe methods to initiate, promote, or enhance immunotherapy of clinically detected cancer, notwithstanding the challenges, if not impossibility, of identification of tumor-specific, or associated antigens, the lack of tumor cell surface membrane expression of major histocompatibility complex (MHC) class I alpha and β2 microglobulin chains, and lack of expression or accessibility of Fas and other natural killer cell immune checkpoint molecules. Conversely, SM synthesis and hydrolysis are increasingly implicated in initiation of carcinogenesis and promotion of metastasis. Surface membrane SM readily forms inter- and intra- molecular hydrogen bond network, which excessive tightness would impair cell-cell contact inhibition, inter- and intra-cellular signals, metabolic pathways, and susceptibility to host immune cells and mediators. The present review aims at clarifying the tumor immune escape mechanisms, which face common immunotherapeutic approaches, and attracting attention to an entirely different, neglected, key aspect of tumorigenesis associated with biochemical changes in the cell surface that lead to failure of contact inhibition, an instrumental tumorigenesis mechanism. Additionally, the review aims to provide evidence for surface membrane SM levels and roles in cells resistance to death, failure to respond to growth suppressor signals, and immune escape, and to suggest possible novel approaches to cancer control and cure.
Recommended Citation
APA Citation
Tallima, H.
Azzazy, H.
&
El Ridi, R.
(2021). Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion. Lipids in Health and Disease, 20(1),
10.1186/s12944-021-01581-y
https://fount.aucegypt.edu/faculty_journal_articles/2797
MLA Citation
Tallima, Hatem, et al.
"Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion." Lipids in Health and Disease, vol. 20,no. 1, 2021,
https://fount.aucegypt.edu/faculty_journal_articles/2797